Medications
Merck, Eli Lilly probed on drug pricing
The Justice Department is probing some drug pricing practices of pharmaceutical giants Merck and Eli Lilly, the companies disclosed Friday in securities filings.
Nov 6, 2015
0
10
Page 39 - News tagged with pharmaceutical drug
Other
Valeant board forms committee to look into Philidor ties
Valeant Pharmaceuticals promised a thorough examination of its dealings with a pharmacy that was targeted in a scathing research report last week, though the company on Monday stood by its financial accounting of that relationship.
Oct 26, 2015
0
4
Medications
The pharmaceutical ethics of stunning drug-price increases
Last week Turing Pharmaceuticals, a startup run by a former hedge-fund manager, raised the price of Daraprim—the standard treatment for toxoplasmosis—from $13.50 to $750 a tablet soon after acquiring the drug from another ...
Oct 2, 2015
2
19
Medications
Does America have the cure for high drug costs?
Soaring prices for everything from cancer treatments to hepatitis C pills that cost more than $100,000 have sparked outcry in the United States in recent years, but calls for change have gone largely unheeded.
Sep 23, 2015
0
34
Oncology & Cancer
Digital 'Rosetta Stone' decrypts how mutations rewire cancer cells
Scientists have discovered how genetic cancer mutations systematically attack the networks controlling human cells, knowledge critical for the future development of personalized precision cancer treatments.
Sep 17, 2015
0
122
Medications
Mylan opens $27.14 billion hostile bid for Perrigo
Shares of Mylan are edging up before the opening bell after the pharmaceutical company went ahead with its hostile, $27.14 billion bid for Perrigo.
Sep 15, 2015
0
4
Other
Valeant will buy eye surgery device maker Synergetics
Canadian drugmaker Valeant Pharmaceuticals said Wednesday it will buy eye surgery product maker Synergetics USA for as much as $192 million.
Sep 2, 2015
0
6
Medications
Valeant steps in to work on psoriasis drug with AstraZeneca
Canadian drugmaker Valeant will work with British competitor AstraZeneca on a potential treatment for psoriasis a few months after biotech giant Amgen said it was ending research on the drug because of a link to suicidal ...
Sep 1, 2015
0
3
Medications
Mylan shareholders approve pursuit of Perrigo
Mylan NV's shareholders approved the company's hostile pursuit of Perrigo Co. and the generic drugmaker hopes to push ahead with a formal offer soon.
Aug 28, 2015
0
5
Health
Poll: Majority in US wants gov't to curb prescription costs
Move over, "Obamacare." A new poll finds Americans worried about medication costs and broadly supporting government action to curb drug prescription prices.
Aug 20, 2015
0
10
